These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 17361225)

  • 81. Insulin-like growth factor 2 expression modulates Taxol resistance and is a candidate biomarker for reduced disease-free survival in ovarian cancer.
    Huang GS; Brouwer-Visser J; Ramirez MJ; Kim CH; Hebert TM; Lin J; Arias-Pulido H; Qualls CR; Prossnitz ER; Goldberg GL; Smith HO; Horwitz SB
    Clin Cancer Res; 2010 Jun; 16(11):2999-3010. PubMed ID: 20404007
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Icariside II induces cell cycle arrest and differentiation via TLR8/MyD88/p38 pathway in acute myeloid leukemia cells.
    Yang J; Lan J; Du H; Zhang X; Li A; Zhang X; Liu Y; Zhang J; Zhang C; Ding Y; Zhang T
    Eur J Pharmacol; 2019 Mar; 846():12-22. PubMed ID: 30579933
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Dependence on PI3K/Akt signaling for malignant rhabdoid tumor cell survival.
    Foster K; Wang Y; Zhou D; Wright C
    Cancer Chemother Pharmacol; 2009 Apr; 63(5):783-91. PubMed ID: 18641990
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Optimisation of a 5-[3-phenyl-(2-cyclic-ether)-methyl-ether]-4-aminopyrrolopyrimidine series of IGF-1R inhibitors.
    Fairhurst RA; Marsilje TH; Stutz S; Boos A; Niklaus M; Chen B; Jiang S; Lu W; Furet P; McCarthy C; Stauffer F; Guagnano V; Vaupel A; Michellys PY; Schnell C; Jeay S
    Bioorg Med Chem Lett; 2016 Apr; 26(8):2057-64. PubMed ID: 26951753
    [TBL] [Abstract][Full Text] [Related]  

  • 85. IGF-1 alleviates serum IgG-induced neuronal cytolysis through PI3K signaling in children with opsoclonus-myoclonus syndrome and neuroblastoma.
    Ding X; Han W; Wang J; Yang W; Chang XF; Zhu ZY; Qin H; Zhang JZ; Wang X; Wang HM
    Pediatr Res; 2019 May; 85(6):885-894. PubMed ID: 30718793
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Insulin-like growth factor 2 axis supports the serum-independent growth of malignant rhabdoid tumor and is activated by microenvironment stress.
    Li T; Wang J; Liu P; Chi J; Yan H; Lei L; Li Z; Yang B; Wang X
    Oncotarget; 2017 Jul; 8(29):47269-47283. PubMed ID: 28521298
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Dependence of Wilms tumor cells on signaling through insulin-like growth factor 1 in an orthotopic xenograft model targetable by specific receptor inhibition.
    Bielen A; Box G; Perryman L; Bjerke L; Popov S; Jamin Y; Jury A; Valenti M; Brandon Ade H; Martins V; Romanet V; Jeay S; Raynaud FI; Hofmann F; Robinson SP; Eccles SA; Jones C
    Proc Natl Acad Sci U S A; 2012 May; 109(20):E1267-76. PubMed ID: 22529373
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Apatinib enhances chemosensitivity of acute myeloid leukemia hl60 cells to cytarabine by inducing apoptosis.
    Pan Q; Wang J; Jiang X; Yang E; Dong L; Gu K
    J BUON; 2019; 24(1):374-381. PubMed ID: 30941994
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Inhibition of the insulin-like growth factor receptor-1 tyrosine kinase activity as a therapeutic strategy for multiple myeloma, other hematologic malignancies, and solid tumors.
    Mitsiades CS; Mitsiades NS; McMullan CJ; Poulaki V; Shringarpure R; Akiyama M; Hideshima T; Chauhan D; Joseph M; Libermann TA; García-Echeverría C; Pearson MA; Hofmann F; Anderson KC; Kung AL
    Cancer Cell; 2004 Mar; 5(3):221-30. PubMed ID: 15050914
    [TBL] [Abstract][Full Text] [Related]  

  • 90. SUMOylation of insulin-like growth factor 1 receptor, promotes proliferation in acute myeloid leukemia.
    Zhang J; Huang FF; Wu DS; Li WJ; Zhan HE; Peng MY; Fang P; Cao PF; Zhang MM; Zeng H; Chen FP
    Cancer Lett; 2015 Feb; 357(1):297-306. PubMed ID: 25448401
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Mechanisms responsible for the synergistic antileukemic interactions between ATR inhibition and cytarabine in acute myeloid leukemia cells.
    Ma J; Li X; Su Y; Zhao J; Luedtke DA; Epshteyn V; Edwards H; Wang G; Wang Z; Chu R; Taub JW; Lin H; Wang Y; Ge Y
    Sci Rep; 2017 Feb; 7():41950. PubMed ID: 28176818
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Insulin-like growth factor 1 receptor signaling regulates embryonic epicardial cell proliferation through focal adhesion kinase pathway.
    Yan Y; Qin Q; Wu L; Jing X; Deng S; She Q
    Acta Biochim Biophys Sin (Shanghai); 2018 Oct; 50(10):976-983. PubMed ID: 30184089
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Dual inhibition of PI3K/mTOR signaling in chemoresistant AML primary cells.
    Bertacchini J; Frasson C; Chiarini F; D'Avella D; Accordi B; Anselmi L; Barozzi P; Forghieri F; Luppi M; Martelli AM; Basso G; Najmaldin S; Khosravi A; Rahim F; Marmiroli S
    Adv Biol Regul; 2018 May; 68():2-9. PubMed ID: 29576448
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Increased expression of insulin-like growth factor i is associated with Ara-C resistance in leukemia.
    Abe S; Funato T; Takahashi S; Yokoyama H; Yamamoto J; Tomiya Y; Yamada-Fujiwara M; Ishizawa K; Kameoka J; Kaku M; Harigae H; Sasaki T
    Tohoku J Exp Med; 2006 Jul; 209(3):217-28. PubMed ID: 16778368
    [TBL] [Abstract][Full Text] [Related]  

  • 95. [Progress in the studies on small molecule IGF-1R inhibitors].
    Xu Y; Wang GS; Sun W; Yang XH; Xu LB
    Yao Xue Xue Bao; 2008 Oct; 43(10):979-84. PubMed ID: 19127859
    [TBL] [Abstract][Full Text] [Related]  

  • 96. IGF1 induces cell proliferation in human pituitary tumors - functional blockade of IGF1 receptor as a novel therapeutic approach in non-functioning tumors.
    Rubinfeld H; Kammer A; Cohen O; Gorshtein A; Cohen ZR; Hadani M; Werner H; Shimon I
    Mol Cell Endocrinol; 2014 Jun; 390(1-2):93-101. PubMed ID: 24769281
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Mechanistic aspects of lauryl gallate-induced differentiation and apoptosis in human acute myeloid leukemia cells.
    Teng CL; Han SM; Wu WC; Hsueh CM; Tsai JR; Hwang WL; Hsu SL
    Food Chem Toxicol; 2014 Sep; 71():197-206. PubMed ID: 24994563
    [TBL] [Abstract][Full Text] [Related]  

  • 98. The novel HSP90 inhibitor NVP-AUY922 shows synergistic anti-leukemic activity with cytarabine in vivo.
    Wendel T; Zhen Y; Suo Z; Bruheim S; Wiedlocha A
    Exp Cell Res; 2016 Jan; 340(2):220-6. PubMed ID: 26748184
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Curcumin enhances the cytogenotoxic effect of etoposide in leukemia cells through induction of reactive oxygen species.
    Papież MA; Krzyściak W; Szade K; Bukowska-Straková K; Kozakowska M; Hajduk K; Bystrowska B; Dulak J; Jozkowicz A
    Drug Des Devel Ther; 2016; 10():557-70. PubMed ID: 26893544
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Enhancement of arabinocytosine (AraC) toxicity to AML cells by a differentiation agent combination.
    Wang X; Harrison JS; Studzinski GP
    J Steroid Biochem Mol Biol; 2016 Nov; 164():72-78. PubMed ID: 26319201
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.